Six days later, tumor growth was confirmed by bioluminescence imaging (BLI), and 3 × 106 CXCR5 or SP6 CAR-T cells were administered i.v. (=day 0 after T cell transfer) (Fig. 5a). The gene discussed is SP6; the disease is neoplasm.